Related Experiment Video
Updated: Feb 23, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
External Validation of Pooled Cohort Risk Equations to Predict 1-Year Clinical Outcome in Ischemic Stroke Patients
Haiyan Li1,2,3,4,5, Runhua Zhang1,2,3,4, Gaifen Liu1,2,3,4
1Stroke Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China (mainland).
Insights
The Pooled Cohort Risk (PCR) equations show potential for predicting 1-year risks of recurrent stroke and vascular events in Chinese patients with acute ischemic stroke (AIS) and transient ischemic attack (TIA). Validation in this population confirms their prognostic value.
Area of Science:
- Neurology
- Cardiology
- Epidemiology
Background:
- The Pooled Cohort Risk (PCR) equations are used to assess cardiovascular risk.
- Validation of these equations in diverse populations, like Chinese patients with ischemic stroke, is crucial for accurate risk stratification.
- Understanding stroke recurrence and vascular event predictors is vital for patient management.
Purpose of the Study:
- To validate the Pooled Cohort Risk (PCR) equations in a Chinese population with ischemic stroke.
- To evaluate the prognostic value of PCR equations in predicting stroke recurrence, coronary heart disease, and vascular death.
- To explore the utility of PCR equations for risk stratification in Chinese acute ischemic stroke (AIS) and transient ischemic attack (TIA) patients.
Main Methods:
- Patients were recruited from the China National Stroke Registry.
- Clinical prediction was assessed using the C statistic.
- Univariate and multivariate logistic regressions were employed to identify risk factors.
- A total of 8287 patients (7652 AIS, 635 TIA) were analyzed with 1-year follow-up.
Main Results:
- The C statistic values for predicting 1-year stroke recurrence ranged from 0.573 to 0.584.
- For non-fatal myocardial infarction, C statistic values were 0.493-0.533.
- Vascular death prediction yielded C statistic values of 0.592.
- AIS patients in the high-PCR group (≥20%) exhibited higher 12-month cumulative rates of recurrent stroke, vascular death, and combined vascular events.
Conclusions:
- Pooled Cohort Risk (PCR) equations demonstrate potential utility in predicting and stratifying 1-year risk for recurrent stroke and combined vascular events in Chinese AIS/TIA patients.
- These equations may serve as valuable tools for clinical decision-making and risk management in this demographic.
- Further research may refine PCR equation application in the Chinese context.
Abstract:
BACKGROUND The present study aimed to validate the pooled cohort risk (PCR) equations in a Chinese ischemic stroke population and to explore its prognostic value in predicting stroke recurrence, coronary heart disease, and vascular death. MATERIAL AND METHODS Patients were selected from the China National Stroke Registry. The C statistic was used to examine the clinical prediction of the scores. To analyze the relevant risk factors, univariate and multivariate logistic regressions were performed. RESULTS Out of a total of 22 216 patients, 8287 patients (including 7652 acute ischemic stroke [AIS] and 635 transient ischemic attack [TIA] patients) were selected and enrolled in the study. At 1-year follow-up, for stroke recurrence rate, the C statistic value was 0.584 in AIS patients and 0.573 in all patients. For non-fatal myocardial infarction, the C statistic value was 0.533 in AIS patients and 0.493 in all patients. For vascular death, the C statistic value was 0.592 in AIS patients and 0.592 in all patients. For all events, the C statistic value was 0.582 in AIS patients and 0.575 in all patients. For AIS patients, the 12-month cumulative rates for recurrent stroke, vascular death, and combined vascular events were higher in the high-PCR group (PCR ≥20%). CONCLUSIONS Pooled cohort risk equations may serve as potential tools to predict and stratify the 1-year risk of recurrent stroke and combined vascular events in AIS/TIA patients in China.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Relative Risk
Cardiac Output II: Effect of Stroke Volume on Cardiac Output
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
